Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A. (Q45868800)
Jump to navigation
Jump to search
scientific article published on 28 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A. |
scientific article published on 28 March 2011 |
Statements
Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®)--an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A (English)
U Martinowitz
J Bjerre
B Brand
R Klamroth
M Misgav
M Morfini
E Santagostino
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference